Maximum quantity allowed is 999
CAS RN: 69655-05-6 | Product Number: D3066
2',3'-Dideoxyinosine

Purity: >98.0%(T)(HPLC)
- ddI
- 9-(2,3-Dideoxy-β-D-ribofuranosyl)-6-oxopurine
- Didanosine
- 9-(2,3-Dideoxy-β-D-ribofuranosyl)hypoxanthine
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
![]() |
---|---|---|---|---|---|
100MG |
NT$1,596
|
1 | 2 | Contact Us | |
500MG |
NT$5,208
|
3 | 0 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
Product Number | D3066 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__0H__1__2N__4O__3 = 236.23 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 500MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 69655-05-6 |
Reaxys Registry Number | 3619529 |
PubChem Substance ID | 87559876 |
SDBS (AIST Spectral DB) | 52174 |
Merck Index (14) | 3098 |
MDL Number | MFCD00077728 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Specific rotation [a]20/D | -26.0 to -30.0 deg(C=0.34, H2O) |
NMR | confirm to structure |
Melting Point | 182 °C |
Specific Rotation | -28° (C=0.34,H2O) |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H373 : May cause damage to organs through prolonged or repeated exposure. H341 : Suspected of causing genetic defects. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | NM7460700 |
H.S.code* | 2940.00-000 |
References
- Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection.
- Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease
- Didanosine: an updated review of its use in HIV infection
- Didanosine enteric-coated capsule: current role in patients with HIV-1 infection
- Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.